- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic heart failure
- Meeting Date: December 2022
- Public Summary Document (PSD) November 2022 OOS 2022 PBAC Meetings - (PDF 857KB)
- Public Summary Document (PSD) November 2022 OOS 2022 PBAC Meetings - (Word 593KB)
Empagliflozin – December 2022
Empagliflozin: Tablet 10 mg; Jardiance® – November 2022 – OOS 2022 PBAC meetings
Last updated
6 April 2023